221 related articles for article (PubMed ID: 21764342)
1. Insight into mechanism of small molecule inhibitors of the MDM2-p53 interaction: molecular dynamics simulation and free energy analysis.
Chen J; Wang J; Xu B; Zhu W; Li G
J Mol Graph Model; 2011 Sep; 30():46-53. PubMed ID: 21764342
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction.
Niu RJ; Zheng QC; Zhang JL; Zhang HX
J Mol Graph Model; 2013 Nov; 46():132-9. PubMed ID: 24211465
[TBL] [Abstract][Full Text] [Related]
3. Computational studies of difference in binding modes of peptide and non-peptide inhibitors to MDM2/MDMX based on molecular dynamics simulations.
Chen J; Zhang D; Zhang Y; Li G
Int J Mol Sci; 2012; 13(2):2176-2195. PubMed ID: 22408446
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling and molecular dynamics simulation studies on pyrrolopyrimidine-based α-helix mimetic as dual inhibitors of MDM2 and MDMX.
Lu SY; Jiang YJ; Zou JW; Wu TX
J Mol Graph Model; 2011 Sep; 30():167-78. PubMed ID: 21820342
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting mechanism of small molecule toward the p53-MDM2 interaction: A molecular dynamic exploration.
Chen J; Wang J; Pang L; Zhu W
Chem Biol Drug Des; 2018 Oct; 92(4):1763-1777. PubMed ID: 29877036
[TBL] [Abstract][Full Text] [Related]
6. Computational analysis of spiro-oxindole inhibitors of the MDM2-p53 interaction: insights and selection of novel inhibitors.
Huang W; Cai L; Chen C; Xie X; Zhao Q; Zhao X; Zhou HY; Han B; Peng C
J Biomol Struct Dyn; 2016; 34(2):341-51. PubMed ID: 25808617
[TBL] [Abstract][Full Text] [Related]
7. Probing Origin of Binding Difference of inhibitors to MDM2 and MDMX by Polarizable Molecular Dynamics Simulation and QM/MM-GBSA Calculation.
Chen J; Wang J; Zhang Q; Chen K; Zhu W
Sci Rep; 2015 Nov; 5():17421. PubMed ID: 26616018
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the Free-Energy Landscape of MDM2 Protein-Ligand Interactions by Steered Molecular Dynamics Simulations.
Hu G; Xu S; Wang J
Chem Biol Drug Des; 2015 Dec; 86(6):1351-9. PubMed ID: 26032728
[TBL] [Abstract][Full Text] [Related]
9. Group-based QSAR and molecular dynamics mechanistic analysis revealing the mode of action of novel piperidinone derived protein-protein inhibitors of p53-MDM2.
Goyal S; Grover S; Dhanjal JK; Tyagi C; Goyal M; Grover A
J Mol Graph Model; 2014 Jun; 51():64-72. PubMed ID: 24858256
[TBL] [Abstract][Full Text] [Related]
10. Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study.
Patil SP; Pacitti MF; Gilroy KS; Ruggiero JC; Griffin JD; Butera JJ; Notarfrancesco JM; Tran S; Stoddart JW
J Comput Aided Mol Des; 2015 Feb; 29(2):155-63. PubMed ID: 25377899
[TBL] [Abstract][Full Text] [Related]
11. A computational analysis of the binding model of MDM2 with inhibitors.
Hu G; Wang D; Liu X; Zhang Q
J Comput Aided Mol Des; 2010 Aug; 24(8):687-97. PubMed ID: 20490618
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic Interactions Are a Key to MDM2 Inhibition by Polyphenols as Revealed by Molecular Dynamics Simulations and MM/PBSA Free Energy Calculations.
Verma S; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Grover A
PLoS One; 2016; 11(2):e0149014. PubMed ID: 26863418
[TBL] [Abstract][Full Text] [Related]
13. Quantum mechanical studies of residue-specific hydrophobic interactions in p53-MDM2 binding.
Ding Y; Mei Y; Zhang JZ
J Phys Chem B; 2008 Sep; 112(36):11396-401. PubMed ID: 18707164
[TBL] [Abstract][Full Text] [Related]
14. Co-operative intra-protein structural response due to protein-protein complexation revealed through thermodynamic quantification: study of MDM2-p53 binding.
Samanta S; Mukherjee S
J Comput Aided Mol Des; 2017 Oct; 31(10):891-903. PubMed ID: 28871352
[TBL] [Abstract][Full Text] [Related]
15. A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings.
Chen J; Wang J; Zhu W; Li G
J Comput Aided Mol Des; 2013 Nov; 27(11):965-74. PubMed ID: 24264557
[TBL] [Abstract][Full Text] [Related]
16. Molecular investigation of the dual inhibition mechanism for targeted P53 regulator MDM2/MDMX inhibitors.
Zhao X; Xiong D; Luo S; Duan L
Phys Chem Chem Phys; 2022 Jul; 24(27):16799-16815. PubMed ID: 35775962
[TBL] [Abstract][Full Text] [Related]
17. An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction.
Sirous H; Chemi G; Campiani G; Brogi S
Comput Biol Chem; 2019 Dec; 83():107105. PubMed ID: 31473433
[TBL] [Abstract][Full Text] [Related]
18. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
19. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99.
Lee XA; Verma C; Sim AYL
Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639
[TBL] [Abstract][Full Text] [Related]
20. Transient protein states in designing inhibitors of the MDM2-p53 interaction.
Bista M; Wolf S; Khoury K; Kowalska K; Huang Y; Wrona E; Arciniega M; Popowicz GM; Holak TA; Dömling A
Structure; 2013 Dec; 21(12):2143-51. PubMed ID: 24207125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
